| Literature DB >> 34214968 |
Jamie E Flerlage1, Susan M Hiniker2, Saro Armenian3, Ellen C Benya4, Adam J Bobbey5, Vivian Chang6, Stacy Cooper7, Don W Coulter8, Branko Cuglievan9, Bradford S Hoppe10, Leidy Isenalumhe11, Kara Kelly12, Leslie Kersun13, Adam J Lamble14, Nicole A Larrier15, Jeffrey Magee16, Kwadwo Oduro17, Martha Pacheco18, Anita P Price19, Kenneth B Roberts20, Christine M Smith21, Aliyah R Sohani22, Erin M Trovillion23, Emily Walling24, Ana C Xavier25, Jennifer L Burns26, Mallory Campbell26.
Abstract
Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.Entities:
Mesh：
Year: 2021 PMID： 34214968 DOI： 10.6004/jnccn.2021.0027
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908